Evidence that synaptic transmission between giant interneurons and identified thoracic interneurons in the cockroach is cholinergic.
In the cockroach, a population of thoracic interneurons (TIs) receives direct inputs from a population of ventral giant interneurons (vGIs). Synaptic potentials in type-A TIs (TIAs) follow vGI action potentials with constant, short latencies at frequencies up to 200 Hz. These connections are important in the integration of directional wind information involved in determining an oriented escape response. The physiological and biochemical properties of these connections that underlie this decision-making process were examined. Injection of hyperpolarizing or depolarizing current into the postsynaptic TIAs resulted in alterations in the amplitude of the post-synaptic potential (PSP) appropriate for a chemical connection. In addition, bathing cells in zero-calcium, high-magnesium saline resulted in a gradual decrement of the PSP, and ultimately blocked synaptic transmission, reversibly. Single-cell choline acetyltransferase (ChAT) assays of vGI somata were performed. These assays indicated that the vGIs can synthesize acetylcholine. Furthermore, the pharmacological specificity of transmission at the vGI to TIA connections was similar to that previously reported for nicotinic, cholinergic synapses in insects, suggesting that the transmitter released by vGIs at these synapses is acetylcholine.
Casagrand
J L
JL
Department of Biology, Case Western Reserve University, Cleveland, Ohio 44106.
Ritzmann
R E
RE
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology; D000818:Animals; D002038:Bungarotoxins / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D066298:In Vitro Techniques; D007395:Interneurons / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D008274:Magnesium / Q000494:pharmacology; D008839:Microelectrodes; D010275:Parasympathetic Nervous System / Q000201:enzymology / Q000502:physiology*; D010277:Parasympathomimetics / Q000494:pharmacology; D010526:Periplaneta / Q000502:physiology*; D013569:Synapses / Q000187:drug effects / Q000201:enzymology / Q000502:physiology*; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*; D013909:Thorax / Q000502:physiology*
D002038:Bungarotoxins; D002800:Cholinesterase Inhibitors; D010277:Parasympathomimetics; D002795:Choline O-Acetyltransferase; D008274:Magnesium; D000109:Acetylcholine; D002118:Calcium